SCHEMBL318739

SCHEMBL318739

CC[C@]1(NC(=O)O)CCCNC1=O

nearest known ligand 0.41

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 6/20 0.35
GRIN1 Q05586 2/20 0.35
GRIN2A Q12879 2/20 0.35
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26670550 0.75 METAP2 (0.33)
SCHEMBL23388889 0.71 GRIN1 (0.34) CCR2GRIN1GRIN2APOLB
SCHEMBL6730153 0.67 GRIN1 (0.38) GRIN1GRIN2APOLB
SCHEMBL17163848 0.67 HPGDS (0.41)
SCHEMBL6608975 0.67 HPGDS (0.41)
SCHEMBL23388812 0.67 POLB (0.46) POLB
SCHEMBL26670525 0.66
SCHEMBL6731661 0.66 TSHR (0.45) CCR2GRIN1GRIN2APOLB
SCHEMBL25134720 0.66 TSHR (0.45) CCR2GRIN1GRIN2APOLB
SCHEMBL2077753 0.66 GRIN1 (0.37) GRIN1GRIN2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2585447-A2 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS Vertex Pharmaceuticals Incorporated (US) 2013-05-01 EP disclosed
WO-2012006055-A2 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-01-12 WO disclosed